- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: ME1100 placebo inhalation solution
Total 4742 results
-
BayerNektar TherapeuticsCompletedPneumonia, BacterialKorea, Republic of, Taiwan, United States, Canada, Philippines, Turkey, Thailand, Australia, Mexico, Colombia, Czechia, Brazil
-
Merck Sharp & Dohme LLCCompleted
-
Novartis PharmaceuticalsCompletedCystic FibrosisUnited States, Germany, United Kingdom, Colombia, Spain, France, Netherlands, Israel, Canada, Italy, Chile, Australia, Hungary, Mexico
-
Pulmotect, Inc.United States Department of DefenseCompleted
-
Cardeas PharmaWithdrawn
-
Apeiron BiologicsApeiron Respiratory Therapies GmbHCompleted
-
Peking University First HospitalCompletedPostoperative Complications | Long-term OutcomeChina
-
Qianfoshan HospitalActive, not recruitingBronchiectasis | Cystic Fibrosis | Lung InfectionChina
-
Novartis PharmaceuticalsCompletedCystic FibrosisSpain, Germany, Switzerland, United Kingdom, Ireland
-
University Hospital, Basel, SwitzerlandNot yet recruitingOverweight and ObesitySwitzerland
-
Aquilon Pharmaceuticals S.A.Terminated
-
Apeptico Forschung und Entwicklung GmbHRecruiting
-
Bitop AGCompleted
-
Bonnie RamseyNational Heart, Lung, and Blood Institute (NHLBI)CompletedCystic FibrosisUnited States
-
Theravance BiopharmaGlaxoSmithKline; Hammersmith Medicines ResearchCompletedPulmonary Disease, Chronic ObstructiveUnited Kingdom
-
Boehringer IngelheimWithdrawn
-
ActelionCompletedPulmonary Fibrosis | Pulmonary HypertensionUnited States
-
Gilead SciencesCompleted
-
Novartis PharmaceuticalsCompleted
-
Aires Pharmaceuticals, Inc.TerminatedPulmonary Arterial HypertensionUnited States, Australia, Hungary
-
Glenmark Specialty S.A.CompletedMild to Moderate Chronic Obstructive Pulmonary Disease (COPD)United States
-
Frontier Biotechnologies Inc.Completed
-
ActelionWithdrawnPulmonary Arterial HypertensionUnited States
-
AstraZenecaCompletedAsthma | Chronic Obstructive Pulmonary Disease COPDUnited States
-
Assistance Publique - Hôpitaux de ParisNot yet recruitingType 2 Diabetes | Bariatric SurgeryFrance
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.RecruitingChronic Obstructive Pulmonary Disease (COPD)China
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Recruiting
-
Kexing Biopharm Co., Ltd.The Third Hospital of Changsha; Guoxin Pharmaceutical Technology (Beijing)... and other collaboratorsActive, not recruitingHealthy ParticipantsChina
-
Gilead SciencesCovance; ClinPhone, Inc.; Chiltern International Inc.CompletedCystic FibrosisBelgium, France, Germany, Italy, Netherlands, Spain, United States, Ireland, United Kingdom, Portugal, Austria, Denmark, Switzerland
-
Green Cross CorporationKorean Center for Disease Control and PreventionCompletedInfluenzaKorea, Republic of
-
Imperial College LondonWithdrawnChronic Obstructive Pulmonary DiseaseUnited Kingdom
-
Saglik Bilimleri UniversitesiRecruiting
-
AlgiPharma ASImperial College London; Cystic Fibrosis Foundation; University Hospital of Cologne and other collaboratorsWithdrawnCystic FibrosisGermany
-
United TherapeuticsCompletedPulmonary Arterial HypertensionUnited States
-
NovartisCompleted
-
Frontier Biotechnologies Inc.RecruitingEvaluate the Efficacy and Safety of FB2001 for Inhalation in Patients With Mild to Moderate COVID-19Mild to Moderate COVID-19China
-
BayerNektar TherapeuticsCompleted
-
Pulmotect, Inc.Completed
-
Hospital Clinic of BarcelonaCompletedVertigo | Hearing Loss | Ear InfectionSpain
-
pH PharmaNot yet recruitingPrimary Open Angle Glaucoma | Ocular HypertensionKorea, Republic of
-
UNION therapeuticsCompleted
-
AstraZenecaCompleted
-
Imperial College LondonCompleted
-
Serodus ASAThe Research Council of Norway; Smerud Medical Research International ASCompletedIsolated Systolic HypertensionUnited Kingdom, Finland, Hungary, Norway
-
Parion SciencesTerminatedDry Eye DiseaseUnited States
-
Eli Lilly and CompanyCompletedSleep Initiation and Maintenance DisordersJapan
-
ORA, Inc.Palatin Technologies, IncCompletedDry Eye DiseaseUnited States
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Singapore
-
Mimetogen Pharmaceuticals USA, Inc.CompletedDry EyeUnited States
-
Mimetogen Pharmaceuticals USA, Inc.CompletedA Safety and Efficacy Study of Tavilermide (MIM-D3) Ophthalmic Solution for the Treatment of Dry EyeKeratoconjunctivitis SiccaUnited States